INS and Alzheimer disease: Cognitive decline represents a critical early manifestation of neurodegenerative disorders such as Alzheimer’s disease (AD), characterized by progressive neuronal dysfunction linked to interconnected pathological mechanisms including cholinergic deficits, oxidative stress, neuroinflammation, synaptic degeneration, and impaired insulin signaling [1,2,3].